Faron Pharmaceuticals - Innovative medical solutions (Part 2)

[Vino_Pino]

@ValkoinenPeura

Why would Medsir fund a study without any income?

This is what I already tried to ask on 27.1.26, but since you guys don’t answer correctly

@Vino_Pino

MEDSIR is mentioned as a sponsor. It’s interesting where it would get its money from in this case if it were the funder. They have a network of top researchers. The EU has also been providing funding https://www.medsir.org/post/we-are-part-of-i3lung-a-project-funded-by-the-european-union.

The sponsor is responsible for the operational execution and the funder bears the financial responsibility.

Medsir’s job is to design and manage trials. Gilead has collaborated; they provided their drugs for one trial https://www.medsir.org/post/medsir-debiopharm-announce-the-first-patient-dosed-in-the-win-b-trial. Roche paid for the whole thing https://www.businesswire.com/news/home/20251212609556/en/Natera-and-MEDSIR-to-Collaborate-on-the-MiRaDoR-Trial-in-Breast-Cancer. It was funded by Roche and sponsored by MEDSIR.

Inderes also reports that MEDSIR is funding, but it’s not clear from that either.

There’s nothing else for it but to ask in the next webcast if necessary or then

@Vino_Pino

We follow the announcements.